EUVIMEDEUVIMED entdecken
Fallbericht

Successful treatment of infantile refractory bullous pemphigoid with baricitinib

Weinan Zhou iD, Yidong Tan iD, Xuanyi Chen, Wenqing Zhang iD, Zhe Sun, Yihang Shen, Zhirong Yao iD, Ruhong Cheng, Yan Gu

Australasian Journal of Dermatology · 2024-12 · 65 (8) · 642-646

DOI: 10.1111/ajd.14345 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 19.07.2024. Verfasst von Weinan Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Azetidines, Pemphigoid, Bullous, Purines, Pyrazoles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Science and Technology innovation action plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infantile bullous pemphigoid (BP) is a rare autoantibody‐mediated skin disorder. We report the effective treatment of a 6‐month‐old infant with BP using baricitinib, a Janus kinase (JAK) inhibitor, after failure with steroids and intravenous immunoglobulin. The patient achieved full remission and discontinued all medications without any relapses. To our knowledge, this is the first case of baricitinib used in an infant with BP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzetidinesPemphigoid, BullousPurinesPyrazolesSulfonamidesHumansInfantJanus Kinase Inhibitors

Stichwörter der Autor:innen

Janus kinase inhibitorsbaricitinibbullous pemphigoidinfanttherapeutics

Substanzen

AzetidinesbaricitinibJanus Kinase InhibitorsPurinesPyrazolesSulfonamides

Autor:innen und Institutionen

  • Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Institute of Dermatology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Allergy, Dermatology Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

ORCID-Profile: Weinan Zhou, Yidong Tan, Wenqing Zhang, Zhirong Yao

Förderung

  • Science and Technology innovation action plan

Zitieren

APA

Zhou, W., Tan, Y., Chen, X., Zhang, W., Sun, Z., Shen, Y., Yao, Z., Cheng, R., & Gu, Y. (2024). Successful treatment of infantile refractory bullous pemphigoid with baricitinib. Australasian Journal of Dermatology, 65(8), 642-646. https://doi.org/10.1111/ajd.14345

Vancouver

Zhou W, Tan Y, Chen X, Zhang W, Sun Z, Shen Y, et al. Successful treatment of infantile refractory bullous pemphigoid with baricitinib. Australasian Journal of Dermatology. 2024;65(8):642-646. doi:10.1111/ajd.14345

BibTeX
@article{Zhou2024,
  author = {Zhou, Weinan and Tan, Yidong and Chen, Xuanyi and Zhang, Wenqing and Sun, Zhe and Shen, Yihang and Yao, Zhirong and Cheng, Ruhong and Gu, Yan},
  title = {Successful treatment of infantile refractory bullous pemphigoid with baricitinib},
  journal = {Australasian Journal of Dermatology},
  year = {2024},
  volume = {65},
  number = {8},
  pages = {642--646},
  doi = {10.1111/ajd.14345}
}
Kostenlos starten →